These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34245772)

  • 1. An update on Alzheimer's disease: Immunotherapeutic agents, stem cell therapy and gene editing.
    Patwardhan AG; Belemkar S
    Life Sci; 2021 Oct; 282():119790. PubMed ID: 34245772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
    Raikwar SP; Thangavel R; Dubova I; Ahmed ME; Selvakumar PG; Kempuraj D; Zaheer S; Iyer S; Zaheer A
    J Alzheimers Dis; 2018; 65(2):321-344. PubMed ID: 30040732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease: Mechanism and Approach to Cell Therapy.
    Amemori T; Jendelova P; Ruzicka J; Urdzikova LM; Sykova E
    Int J Mol Sci; 2015 Nov; 16(11):26417-51. PubMed ID: 26556341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current viral-mediated gene transfer research for treatment of Alzheimer's disease.
    Sasmita AO
    Biotechnol Genet Eng Rev; 2019 Apr; 35(1):26-45. PubMed ID: 30317930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau immunotherapies for Alzheimer's disease.
    Hoskin JL; Sabbagh MN; Al-Hasan Y; Decourt B
    Expert Opin Investig Drugs; 2019 Jun; 28(6):545-554. PubMed ID: 31094578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why delay in effective treatment for Alzheimer's disease and related conditions.
    Iqbal K; Liu F; Gong C; Dai C; Hu W
    Prog Mol Biol Transl Sci; 2019; 168():243-256. PubMed ID: 31699318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
    Kulshreshtha A; Piplani P
    Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises.
    Taupin P
    Curr Alzheimer Res; 2009 Dec; 6(6):461-70. PubMed ID: 19747153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
    Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
    Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
    Si Z; Wang X
    J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Alzheimer's disease.
    Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.
    Grubman A; Kanninen KM; Malm T
    J Mol Neurosci; 2016 Nov; 60(3):390-404. PubMed ID: 27660215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.
    Kastanenka KV; Bussiere T; Shakerdge N; Qian F; Weinreb PH; Rhodes K; Bacskai BJ
    J Neurosci; 2016 Dec; 36(50):12549-12558. PubMed ID: 27810931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One hundred years of Alzheimer's disease: immunotherapy a hope?].
    Behrens P MI; Vergara E F
    Rev Med Chil; 2007 Jan; 135(1):103-10. PubMed ID: 17369991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell therapy for Alzheimer's disease.
    Abdel-Salam OM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance.
    Wang YJ; Zhou HD; Zhou XF
    J Alzheimers Dis; 2010; 21(4):1065-75. PubMed ID: 21504118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy.
    Güell-Bosch J; Lope-Piedrafita S; Esquerda-Canals G; Montoliu-Gaya L; Villegas S
    NMR Biomed; 2020 May; 33(5):e4263. PubMed ID: 32067292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.